Via Hemp Gazette Canadian-headquartered Tilray Brands, Inc. says it is expanding its medical cannabis product offerings for patients and related education for health professionals in Australia. Accessible via Australia’s Therapeutic Goods Administration (TGA) Special Access Scheme and Authorized Prescriber Scheme (where individual applications are approved), whole flower options including 1:1 (THC 10 CBD 10), mid-range […]
DENVER–(BUSINESS WIRE)–The Emerald Conference, curated by the Emerald Conference’s Scientific Committee, returns in person, February 27-March 1, 2022 to the ... Read More
It's a foregone conclusion that gummies are the cornerstone of the legal edibles market, especially on the West Coast. When convenience, discretion, and precise dosing are the name of the…
TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced that Endocanna Health (“Endocanna”), a ... Read More
It’s been a whirlwind rise for psychedelics in general in the past few years, with tons of research into medical properties, and new legal policies being set in different parts of the country to allow medical use, or decriminalize recreational use. What’s in store for this class of drugs? Here are my 2022 predictions for […]
Pennsylvania is set to become a national, and possibly global, leader in psilocybin research, thanks to a new bill that was recently introduced in the House of Representatives. The bill passed a Health Committee vote in Harrisburg and is on its way for votes in the house and senate. Titled the Public Health Benefits of […]
We have reached a turning point in the cannabis industry, where, as consumers, we now have more choices than we know what to do with. When I was younger, shopping for weed consisted of calling one of the 3 or 4 dealers in my area and picking up whatever flower strain was available from whoever […]
In this week’s update on patents – India requests emergency meeting of WTO General Council to discuss patent waiver; RGNIIPM announces online advanced training program on patent specification; Taiwan’s revised ‘Accelerated Examination Program’ (AEP) comes into effect from January 01, 2022; USPTO pushes deadline for applications under COVID-19 Prioritized Pilot Program to March 31st, 2022; Novartis announces CAFC ruling on validity of Gilenya patent; Intel can challenge two of Qualcomm’s smartphone patents, says U.S. Court of Appeals. India related patent…
BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan ... Read More